Daiichi Sankyo's R&D expenditure FY 2012-2017

The statistic presents the annual research and development expenses of Daiichi Sankyo Co., Ltd. in fiscal years 2012 to 2017. In fiscal year 2017, the Japanese pharmaceutical company spent approximately 236 billion Japanese yen on R&D, up from about 184 billion yen in fiscal 2012.

Annual research and development expenses of Daiichi Sankyo Co., Ltd. in fiscal years 2012 to 2017

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

December 2018

Region

Japan

Survey time period

fiscal years 2012 to 2017; the company’s fiscal year starts on April 1 of the stated year and ends on March 31 of the following year

Supplementary notes

Figures are based on International Financial Reporting Standards (IFRS).
1 Japanese yen equals 0.009 U.S. dollars or 0.0081 euros as of May 2019.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.